Bicycle Therapeutics (FRA:50BA) FCF Yield % : -36.66 (As of Apr. 10, 2025)

View and export this data going back to 2019. Start your Free Trial

What is Bicycle Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Bicycle Therapeutics's Trailing 12-Month Free Cash Flow is €-152.66 Mil, and Market Cap is €390.98 Mil. Therefore, Bicycle Therapeutics's FCF Yield % for today is -36.66%.

The historical rank and industry rank for Bicycle Therapeutics's FCF Yield % or its related term are showing as below:

FRA:50BA' s FCF Yield % Range Over the Past 10 Years
Min: -56.06 Med: -8.36 Max: -0.95
Current: -36.66

During the past 8 years, the highest FCF Yield % of Bicycle Therapeutics was -0.95%. The lowest was -56.06%. And the median was -8.36%.

FRA:50BA's FCF Yield % is ranked worse than
65.95% of 1498 companies
in the Biotechnology industry
Industry Median: -16.365 vs FRA:50BA: -36.66

Bicycle Therapeutics's FCF Margin % for the quarter that ended in Dec. 2024 was -263.32%.

Bicycle Therapeutics FCF Yield % Historical Data

The historical data trend for Bicycle Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bicycle Therapeutics FCF Yield % Chart

Bicycle Therapeutics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Yield %

Get a 7-Day Free Trial

-5.03

-1.01

-12.49

-8.48

-17.26

Bicycle Therapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Yield %	Get a 7-Day Free Trial															-25.26	-28.07	-12.85	-10.62	-4.06

Competitive Comparison of Bicycle Therapeutics's FCF Yield %

For the Biotechnology subindustry, Bicycle Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bicycle Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bicycle Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Bicycle Therapeutics's FCF Yield % falls into.

Save Embed

;

Save Embed

;

Bicycle Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Bicycle Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-158.49	/	918.5113
	=	-17.26%

Bicycle Therapeutics's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-9.324	*	4	/	918.5113
	=	-4.06%

Bicycle Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Bicycle Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Bicycle Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Bicycle Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bicycle Therapeutics PLC (FRA:50BA) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

BCYC:USA 50BA:Germany

Address

Granta Park, Great Abington, Blocks A and B, Portway Building, Cambridge, GBR, CB21 6GS

Website

https://www.bicycletherapeutics.com

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Bicycle Therapeutics Headlines

No Headlines